Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meletios A Dimopoulos

Showing results (421-430 of 740) with videos related to

Pageof 74
Sort By:
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 25, 2022
Pulmonary function tests reveal unrecognised lung dysfunction and have independent prognostic significance in patients with systemic AL amyloidosisGeorgia Trakada, Despina Fotiou, Anastasios Kallianos, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 20, 2023
Real World Efficacy and Toxicity of Selinexor: Importance of Patient Characteristics, Dose Intensity and Post Progression OutcomesEfstathios Kastritis, Maria Gavriatopoulou, Eirini Solia, et al.
European Journal of Haematology|May 19, 2010
High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agentsEvangelos Terpos, Eirini Katodritou, Maria Roussou, et al.
American Journal of Hematology|August 12, 2021
Isatuximab plus pomalidomide and dexamethasone in frail patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysisFredrik Schjesvold, Sara Bringhen, Paul G Richardson, et al.
Blood Cancer Journal|March 4, 2020
Consolidation with carfilzomib, lenalidomide, and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism, in the absence of bisphosphonates, among newly diagnosed patients with multiple myelomaMaria Gavriatopoulou, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, et al.
American Journal of Hematology|February 19, 2016
Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysisMeletios A Dimopoulos, Maria Roussou, Maria Gavriatopoulou, et al.
Blood Cancer Journal|September 26, 2020
The Role of Low Dose Whole Body CT in the Detection of Progression of Patients with Smoldering Multiple MyelomaMaria Gavriatopoulou, Andriani Βoultadaki, Vassilis Koutoulidis, et al.
Blood Advances|September 16, 2021
Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2: a prospective studyMaria Gavriatopoulou, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, et al.
Journal of Cellular and Molecular Medicine|October 1, 2019
Non-lethal proteasome inhibition activates pro-tumorigenic pathways in multiple myeloma cellsAikaterini Skorda, Aimilia D Sklirou, Theodore Sakellaropoulos, et al.
European Journal of Haematology|March 24, 2009
Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myelomaEdward A Stadtmauer, Donna M Weber, Ruben Niesvizky, et al.
Pageof 74

Showing results (421-430 of 740) with videos related to

Sort By:
Pageof 74
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 25, 2022
Pulmonary function tests reveal unrecognised lung dysfunction and have independent prognostic significance in patients with systemic AL amyloidosisGeorgia Trakada, Despina Fotiou, Anastasios Kallianos, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 20, 2023
Real World Efficacy and Toxicity of Selinexor: Importance of Patient Characteristics, Dose Intensity and Post Progression OutcomesEfstathios Kastritis, Maria Gavriatopoulou, Eirini Solia, et al.
European Journal of Haematology|May 19, 2010
High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agentsEvangelos Terpos, Eirini Katodritou, Maria Roussou, et al.
American Journal of Hematology|August 12, 2021
Isatuximab plus pomalidomide and dexamethasone in frail patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysisFredrik Schjesvold, Sara Bringhen, Paul G Richardson, et al.
Blood Cancer Journal|March 4, 2020
Consolidation with carfilzomib, lenalidomide, and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism, in the absence of bisphosphonates, among newly diagnosed patients with multiple myelomaMaria Gavriatopoulou, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, et al.
American Journal of Hematology|February 19, 2016
Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysisMeletios A Dimopoulos, Maria Roussou, Maria Gavriatopoulou, et al.
Blood Cancer Journal|September 26, 2020
The Role of Low Dose Whole Body CT in the Detection of Progression of Patients with Smoldering Multiple MyelomaMaria Gavriatopoulou, Andriani Βoultadaki, Vassilis Koutoulidis, et al.
Blood Advances|September 16, 2021
Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2: a prospective studyMaria Gavriatopoulou, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, et al.
Journal of Cellular and Molecular Medicine|October 1, 2019
Non-lethal proteasome inhibition activates pro-tumorigenic pathways in multiple myeloma cellsAikaterini Skorda, Aimilia D Sklirou, Theodore Sakellaropoulos, et al.
European Journal of Haematology|March 24, 2009
Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myelomaEdward A Stadtmauer, Donna M Weber, Ruben Niesvizky, et al.
Pageof 74